1. Home
  2. NMAD vs OKYO Comparison

NMAD vs OKYO Comparison

Compare NMAD & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Power Solutions Inc. Common Stock

NMAD

Nomad Power Solutions Inc. Common Stock

HOLD

Current Price

$2.40

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Logo OKYO Pharma Limited

OKYO

OKYO Pharma Limited

SELL

Current Price

$1.09

Market Cap

78.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NMAD
OKYO
Founded
2020
2007
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
78.2M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
NMAD
OKYO
Price
$2.40
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
260.9K
★ 282.3K
Earning Date
11-16-2026
07-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.75
N/A
EPS
N/A
★ N/A
Revenue
★ $200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$1.00
52 Week High
$6.40
$3.20

Technical Indicators

Market Signals
Indicator
NMAD
OKYO
Relative Strength Index (RSI) 32.30 33.79
Support Level N/A N/A
Resistance Level $4.35 $1.70
Average True Range (ATR) 0.49 0.13
MACD -0.13 -0.03
Stochastic Oscillator 11.30 20.23

Price Performance

Historical Comparison
NMAD
OKYO

About NMAD Nomad Power Solutions Inc. Common Stock

Nomad Power Solutions Inc is a pioneering mobile, utility-grade truck-transportable battery energy storage system. The company's first-to-market products provide one megawatt of instantaneous power to an electrical grid or facility, bypassing months of construction typically required for traditional fixed installations. Its patented platforms, which are deployed on semi-trailers, serve emerging AI-driven applications, along with utilities, industrial operators, government agencies, and critical infrastructure providers through equipment sales, rentals and Energy-as-a-Service offerings. The group's products are Traveler, Voyager Eagle, Voyager Falcon, Voyager Hawk, and Compare Products. Its applications are Utilities, Peak Shaving, EV Charging, and Mining.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

Share on Social Networks: